Abstract：Objective To evaluate the status of glucose, blood pressure and lipid control among patients with type 2 diabetes mellitus in Changshu City, and to explore their influencing factors so as to provide a basis for optimizing the management of diabetes mellitus in communities.Methods We investigated 10,238 type 2 diabetes mellitus patients managed by communities in Changshu City in 2013, and then evaluated the standard-reaching situation of glucose, blood pressure and lipid according to the comprehensive control goal of Chinese Diabetes Society.Results The average levels of hemoglobin A1c (HbAlc), systolic blood pressure (SPB) and diastolic blood pressure (DPB) in the 10,238 surveyed subjects were (7.60 ±1.58)%, (150.06 ±20.05) mmHg and (80.76±10.33) mmHg respectively, with the compliance ratios being 40.84% (HbAlc<7.0%), 32.01% and 46.07% respectively. The proportion of both SPB and DPB simultaneously reaching the control target (<140/80 mmHg) was 22.33%. The mean values of triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were (1.96±1.60) mmol/L,(5.24 ±1.11)mmol/L, (1.50±0.41) mmol/L and (3.13±0.90) mmol/L, with the compliance ratios being 56.80%, 23.82%, 78.43% and 25.22% respectively. The mean values of the above-mentioned blood lipid indexes except HDL-C were higher than the target values of diabetes comprehensive control, and the differences were statistically significant (all P<0.05). Multi-factor unconditional logistic regression analysis showed that residence (OR=1.310,95%CI:1.242-1.470), blood lipid(OR=1.257, 95%CI:1.156-1.367), smoking(OR=1.297, 95%CI:1.082-1.554), waist circumference(OR=1.290, 95%CI:1.184-1.404), sex (OR=0.698, 95%CI:0.638-0.763), age(OR=0.897,95%CI:0.854-0.941), pharmacotherapy(OR=1.244, 95%CI:1.208-1.282), SPB(OR=1.208, 95%CI:1.104-1.322)and diabetes course(OR=1.517, 95%CI:1.450-1.588) were the independent factors influencing glucose control.Conclusions The control rates of glucose, blood pressure and lipid of type 2 diabetic patients in Changshu City in 2013 was not satisfactory, and the influencing factors were residence, smoking, sex, age, pharmacotherapy, course of diabetes, blood lipid, waist circumference, SBP and so on. Comprehensive measures should be carried out to control glucose and occurrence of complications of diabetes.
顾亦斌, 薛雨星, 盛红艳, 张蒙. 2013年常熟市2型糖尿病患者的血糖、血脂及血压控制情况及影响因素分析[J]. 实用预防医学, 2019, 26(7): 836-840.
GU Yi-bin, XUE Yu-xing, SHENG Hong-yan, ZHANG Meng. Status and influencing factors of glucose, blood lipid and blood pressurecontrol among patients with type 2 diabetes mellitus in Changshu City, 2013. , 2019, 26(7): 836-840.
[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J]中华内分泌代谢杂志,2014,30(10):893-942. [2] Cheung BM, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.[J]. Am J Med,2009, 122(5):443-453. [3] Hanefeld M, Schnauer M, Forst T.Glycemic control and cardiovascular benefit: what do we know today?[J].Dtsch Med Wochenschr,2010, 135(7):301-307. [4] Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes[J]. JAMA,2004, 291(3):335-342. [5] Xu Y,Wang L,He J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA, 310(9):948-959. [6] 朱婕,吴寿岭,王艳秀,等.高敏C反应蛋白对新发脑出血危险的预测价值研究[J].中华内科杂志,2010,49(6):469-472. [7] Aluli NE, Reyes PW, Brady SK, et al. All-cause and CVD mortality in Native Hawaiians[J]. Diabetes Res Clin Pract,2010, 89(1):65-71. [8] 裘项旭,胡美君,叶响荣.糖尿病并发眼病相关危险因素分析[J].实用预防医学,2015, 22(2):211-213. [9] Use AB. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38.UK Prospective Diabetes Study Group[J]. BMJ, 1998, 317(7160):703-713. [10] Adler AI, Stratton IM, Neil HA,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study[J]. BMJ, 2000, 321(7258):412-419. [11] 陈磊, 王芳, 杨智鹏,等.社区2型糖尿病患者合并代谢综合征不同组分血脂谱分析[J].实用预防医学,2019,26(2):199-202. [12] 林洁.上海某社区卫生服务中心降血脂药物的应用[J]. 公共卫生与预防医学,2014, 25(2):83-84. [13] 张建飞,潘红珍,邱作奇,等. 非高密度脂蛋白胆固醇与2型糖尿病大血管病变的相关性分析[J].现代实用医学, 2015, 27(2):253-255. [14] Guh DP, Wei Z, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis[J]. BMC Public Health, 2009, 9(1):88. [15] Wilding JP. The importance of weight management in type 2 diabetes mellitus[J].Int J Clin Pract,2014, 68(6):682-691. [16] Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes[J]. Diabetes Care,2011, 34(7):1481-1486. [17] 饶明俐.《中国脑血管病防治指南》摘要[J].中风与神经疾病杂志,2006,23(1):4-8.
2019, Vol. 26 
